Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2001
08/02/2001WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
08/02/2001WO2001055173A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055170A1 Mob-5/hmob-5 as a cancer diagnostic marker
08/02/2001WO2001055163A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001054733A1 Nucleic acids, proteins and antibodies
08/02/2001WO2001054732A1 Antibodies against ctla4 (cd152), conjugates comprising same, and uses thereof
08/02/2001WO2001054723A1 Therapeutic method for reducing angiogenesis
08/02/2001WO2001054722A1 Pre-transplant accommodated organs resistant to anti-donor immunity
08/02/2001WO2001054721A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
08/02/2001WO2001054474A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001054473A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001019997A3 BASB128 polypeptide and polynucleotide from moxarella catarrhalis
08/02/2001WO2001018550A3 Determination of adrenomedullin-binding proteins
08/02/2001WO2001018059A3 Congener independent detection of microcystin and nodularin congeners
08/02/2001WO2001016303A3 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis
08/02/2001WO2001014548A3 New g-protein coupled receptor and dna sequences thereof
08/02/2001WO2001006226A3 Methods for determining the proliferation activity of cells
08/02/2001WO2001005950A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
08/02/2001WO2001004305A3 Human proteins involved in detoxification
08/02/2001WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer
08/02/2001WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex
08/02/2001WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/02/2001WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/02/2001WO2000026241A9 Novel compositions and methods of screening for t-cell and b-cell activation modulators
08/02/2001US20010011127 Modulating activity of endogenous protein
08/02/2001US20010011125 Genetic engineering; grafting antibodies
08/02/2001US20010011124 Genetic engineering
08/02/2001US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides
08/02/2001US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis
08/02/2001US20010010929 Polynucleotides and polypeptides belonging to the uncoupling proteins family
08/02/2001US20010010927 A method for screening candidate pesticides using a receptor that binds bacillus thuringiensis toxin
08/02/2001US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's
08/02/2001US20010010920 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation
08/02/2001US20010010918 Immunological assay for spongiform encephalopathies
08/02/2001US20010010913 Isolated polypeptide
08/02/2001US20010010912 nrdF
08/02/2001US20010010908 Reagents and methods useful for detecting diseases of the prostate
08/02/2001US20010010904 Genetic engineering; overlapping Dna sequences
08/02/2001US20010010901 Genetic engineering
08/02/2001US20010010821 For treatment of gastrointestinal disorders
08/02/2001US20010010820 Delaying onset of insulin dependent diabetes mellitus by administering immunologically active monoclonal antibody against glutamic acid decarboxylase coupled to a nonimmunogenic polymer that provides shell around antibody
08/02/2001US20010010819 Septicemia
08/02/2001US20010010817 Tumor derived carbohydrate binding protein
08/02/2001EP1144607A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
08/02/2001DE10001377A1 bHLH-Transkriptionsfaktor ASCL3 und diesen enthaltendes Arzneimittel bHLH transcription factor AsCl3 and this medicinal product containing
08/02/2001DE10001372A1 Anti-CD3-Einzelketten-Antikörper mit humanem Cmu3- und Cmu4- Domänen Anti-CD3 single-chain antibody with human Cmu3- and Cmu4- domains
08/02/2001CA2401086A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
08/02/2001CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
08/02/2001CA2398564A1 Nuclear hormone receptors
08/02/2001CA2398554A1 Novel nucleic acids and polypeptides
08/02/2001CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
08/02/2001CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides
08/02/2001CA2398503A1 Therapeutic method for reducing angiogenesis
08/02/2001CA2398466A1 Ultra high affinity neutralizing antibodies
08/02/2001CA2398430A1 Human protein kinases and protein kinase-like enzymes
08/02/2001CA2398411A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
08/02/2001CA2398284A1 Methods and compositions for generating human monoclonal antibodies
08/02/2001CA2398283A1 Peptide fragments of colostrinin and their use
08/02/2001CA2398242A1 Fil-1 theta dnas and polypeptides
08/02/2001CA2398227A1 17 human secreted proteins
08/02/2001CA2398003A1 Phosphodiesterases
08/02/2001CA2397839A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2397407A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395885A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395872A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395858A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
08/02/2001CA2395827A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395816A1 Nucleic acids, proteins and antibodies
08/02/2001CA2395787A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395734A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395693A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395676A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395671A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395666A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395654A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395403A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395398A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395295A1 Nucleic acids, proteins and antibodies
08/02/2001CA2395178A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2394841A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2394039A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393954A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393912A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393652A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393618A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393002A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392757A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392751A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392438A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392428A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392422A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2392398A1 Nucleic acids, proteins, and antibodies
08/01/2001EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them
08/01/2001EP1119629A2 Oxidoreductase molecules
08/01/2001EP1119625A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
08/01/2001EP1119623A1 Mage-a3 peptides presented by hla class ii molecules
08/01/2001EP1119621A2 G-protein coupled receptor proteins
08/01/2001EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses
1 ... 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 ... 1494